Early Access — free while we kick the tires
EdgarHawk

Kreitzer Anatol

Chief Discovery Officer

Officer

Latest: Chief Discovery Officer selling · April 2026

1 filing analyzed · 1 company · Latest 2026-04-29

Companies

Company Buys Sells Direction
MapLight Therapeutics, Inc. MPLT 0 3 Net selling

Activity

April 2026
medium
Sell
45,422 shares
$1,347,066
Significance 6/10

MapLight Chief Discovery Officer Kreitzer sells 45,422 shares worth $1.35M as stock surges

Kreitzer Anatol, MapLight's Chief Discovery Officer, executed a substantial liquidation of 45,422 shares across three tranches, totaling approximately $1.35 million, on a single day as the stock rallied sharply. The company is unprofitable with significant operating losses, and Kreitzer's sale occurred while the stock was recovering from a deep trough—recently rebounding strongly but still trading below its recent highs. This represents meaningful position reduction by an officer with direct knowledge of drug discovery operations, though the timing during a strong price recovery suggests profit-taking rather than distress selling. The liquidation's size and concentration in one trading day, combined with the company's ongoing path to profitability, warrants scrutiny into whether this reflects confidence in near-term catalysts or confidence in the recent appreciation itself.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access